|
UA73073C2
(uk)
*
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
US6002008A
(en)
*
|
1997-04-03 |
1999-12-14 |
American Cyanamid Company |
Substituted 3-cyano quinolines
|
|
AUPP003197A0
(en)
*
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
|
NZ507760A
(en)
|
1998-03-26 |
2002-10-25 |
Japan Tobacco Inc |
Amide derivatives and nociceptin antagonists
|
|
US7045519B2
(en)
|
1998-06-19 |
2006-05-16 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
GB9822440D0
(en)
|
1998-10-14 |
1998-12-09 |
Smithkline Beecham Plc |
Medicaments
|
|
WO2000078351A1
(en)
*
|
1999-06-18 |
2000-12-28 |
Mitsubishi Pharma Corporation |
Osteogenesis promoters
|
|
WO2001017562A1
(fr)
*
|
1999-09-02 |
2001-03-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Agents promoteurs de l'osteogenese
|
|
SE9903611D0
(sv)
*
|
1999-10-06 |
1999-10-06 |
Astra Ab |
Novel compounds III
|
|
DK1320531T3
(da)
*
|
2000-08-10 |
2011-01-03 |
Pfizer Italia Srl |
Bicyclo-pyrazoler, der er aktive som kinase inhibitorer, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, der indeholder disse
|
|
DE10060145C1
(de)
*
|
2000-12-04 |
2002-06-13 |
Michael Wackernagel |
Chinolin-Derivate, ihre Verwendung und diese enthaltende pharmazeutische Zusammensetzung
|
|
CN1486302A
(zh)
*
|
2000-12-07 |
2004-03-31 |
CV���ƹ�˾ |
作为抗冠状动脉疾病或动脉硬化的abca-1加强化合物的取代1,3,5-三嗪和嘧啶
|
|
AR038658A1
(es)
*
|
2001-06-15 |
2005-01-26 |
Novartis Ag |
Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
|
|
GB0130341D0
(en)
*
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
|
GB0230015D0
(en)
*
|
2002-12-23 |
2003-01-29 |
Novartis Ag |
Organic compounds
|
|
UA80607C2
(en)
*
|
2003-04-09 |
2007-10-10 |
White Holdings Corp |
Process for the preparation of 3-cyano-6-alkoxy-7-nitro-4-quinolines
|
|
DE10331675A1
(de)
*
|
2003-07-14 |
2005-02-10 |
Bayer Cropscience Ag |
Hetarylsubstituierte Pyrazolidindion-Derivate
|
|
MXPA06003951A
(es)
|
2003-10-07 |
2006-06-27 |
Renovis Inc |
Derivados de amida como ligandos del canal de ion y composiciones farmaceuticas y sus metodos de uso.
|
|
KR20080095915A
(ko)
*
|
2004-05-06 |
2008-10-29 |
워너-램버트 캄파니 엘엘씨 |
4-페닐아미노-퀴나졸린-6-일-아미드
|
|
JP4470940B2
(ja)
*
|
2004-05-12 |
2010-06-02 |
宇部興産株式会社 |
エチニル基置換縮合ヘテロ環化合物重金属錯体、その製造法、その合成中間体及びその製造法並びに有機エレクトロルミネッセンス素子
|
|
FR2873695A1
(fr)
*
|
2004-07-30 |
2006-02-03 |
Palumed Sa |
Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
FR2874922A1
(fr)
*
|
2004-07-30 |
2006-03-10 |
Palumed Sa |
Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
BRPI0514381A
(pt)
*
|
2004-07-30 |
2008-06-10 |
Palumed Sa |
compostos hìbridos de aminoquinolina-antibiótico, composições farmacêuticas, método de preparação e uso destes
|
|
WO2006040645A1
(en)
*
|
2004-10-11 |
2006-04-20 |
Ranbaxy Laboratories Limited |
N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
|
|
US7875627B2
(en)
*
|
2004-12-07 |
2011-01-25 |
Abbott Laboratories |
Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
RU2007131400A
(ru)
|
2005-03-01 |
2009-04-10 |
Вайет (Us) |
Соединения циннолина и их применение в качестве модуляторов х-рецепторов печени
|
|
ES2351613T3
(es)
*
|
2005-03-03 |
2011-02-08 |
Santen Pharmaceutical Co., Ltd. |
Nuevo compuesto cíclico que tiene un grupo quinolilalquiltio.
|
|
WO2007098214A1
(en)
*
|
2006-02-21 |
2007-08-30 |
Amgen Inc. |
Cinnoline derivatives as phosphodiesterase 10 inhibitors
|
|
US20090099175A1
(en)
*
|
2006-03-01 |
2009-04-16 |
Arrington Mark P |
Phosphodiesterase 10 inhibitors
|
|
WO2007103554A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Amgen Inc. |
Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
|
|
CN101679357A
(zh)
*
|
2007-05-09 |
2010-03-24 |
辉瑞大药厂 |
取代的杂环衍生物及其组合物和作为抗菌剂的药物用途
|
|
WO2010144611A2
(en)
*
|
2009-06-10 |
2010-12-16 |
3-V Biosciences, Inc. |
Antivirals that target transporters, carriers, and ion channels
|
|
CN103539734B
(zh)
*
|
2013-09-25 |
2015-10-14 |
上海交通大学 |
3-烯丙基喹啉的制备方法
|
|
US20200347038A1
(en)
|
2014-08-29 |
2020-11-05 |
Russell Dahl |
Quinolines that modulate serca and their use for treating disease
|
|
US20170281611A1
(en)
*
|
2014-08-29 |
2017-10-05 |
Eiger Biopharmaceuticals, Inc. |
Quinolines and their use for treating endoplasmic reticulum stress-caused diseases
|
|
US9932310B2
(en)
*
|
2016-02-08 |
2018-04-03 |
City Of Hope |
DNA2 inhibitors for cancer treatment
|
|
US11730729B2
(en)
|
2020-07-20 |
2023-08-22 |
Neurodon Corporation |
Quinolines that modulate SERCA and their use for treating disease
|
|
US12486269B2
(en)
|
2024-02-08 |
2025-12-02 |
Aconcagua Bio, Inc. |
Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
|
|
WO2025171341A2
(en)
*
|
2024-02-08 |
2025-08-14 |
Aconcagua Bio, Inc. |
Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
|